• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular and cellular prostate biology: origin of prostate-specific antigen expression and implications for benign prostatic hyperplasia.

作者信息

Schalken J A

机构信息

Department of Urology, University of Nijmegen, The Netherlands.

出版信息

BJU Int. 2004 Mar;93 Suppl 1:5-9. doi: 10.1111/j.1464-410x.2003.04633.x.

DOI:10.1111/j.1464-410x.2003.04633.x
PMID:15009079
Abstract
摘要

相似文献

1
Molecular and cellular prostate biology: origin of prostate-specific antigen expression and implications for benign prostatic hyperplasia.分子与细胞前列腺生物学：前列腺特异性抗原表达的起源及其对良性前列腺增生的影响
BJU Int. 2004 Mar;93 Suppl 1:5-9. doi: 10.1111/j.1464-410x.2003.04633.x.
2
Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.对来自良性前列腺增生和前列腺癌的原代细胞培养物进行MENT评估。
Int J Androl. 2009 Dec;32(6):607-15. doi: 10.1111/j.1365-2605.2008.00906.x. Epub 2008 Jul 9.
3
Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.熊果酸可缩小良性前列腺增生大鼠模型的前列腺体积并降低二氢睾酮水平。
Food Chem Toxicol. 2012 Mar;50(3-4):884-8. doi: 10.1016/j.fct.2012.01.007. Epub 2012 Jan 15.
4
Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.过氧化物酶体增殖物激活受体-α激动剂非诺贝特在治疗大鼠诱导性伴有发育异常改变的良性前列腺增生中的作用
Fundam Clin Pharmacol. 2018 Dec;32(6):617-626. doi: 10.1111/fcp.12384. Epub 2018 Jun 28.
5
Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.非那雄胺对良性前列腺增生组织雄激素浓度的差异作用。
Clin Endocrinol (Oxf). 1997 Feb;46(2):137-44. doi: 10.1046/j.1365-2265.1997.950908.x.
6
Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer.前列腺特异性抗原、其分子形式及其他用于检测前列腺癌的激肽释放酶标志物。
Urology. 2002 Jan;59(1):2-8. doi: 10.1016/s0090-4295(01)01449-2.
7
Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.一种源自良性前列腺组织的人前列腺上皮细胞系中雄激素受体的特征：RC-165N/人端粒酶逆转录酶
Prostate Cancer Prostatic Dis. 2007;10(1):30-8. doi: 10.1038/sj.pcan.4500915. Epub 2006 Oct 31.
8
Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.良性前列腺增生男性中前列腺特异性抗原变化与前列腺上皮百分比之间的关系。
Urology. 1995 May;45(5):795-800. doi: 10.1016/s0090-4295(99)80086-7.
9
Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.前列腺增生中的双氢睾酮。II. 肥大犬前列腺中双氢睾酮的形成与含量以及双氢睾酮对犬前列腺生长的影响
J Clin Invest. 1970 Sep;49(9):1746-53. doi: 10.1172/JCI106392.
10
Developmental, cellular and molecular biology of benign prostatic hyperplasia.良性前列腺增生的发育、细胞与分子生物学
Differentiation. 2011 Nov-Dec;82(4-5):165-7. doi: 10.1016/j.diff.2011.08.005. Epub 2011 Aug 30.

引用本文的文献

1
Case report: Two cases of prostate adenocarcinoma progressing to rare sarcomatoid carcinoma with normal PSA levels following endocrine therapy.病例报告：两例前列腺腺癌在内分泌治疗后进展为罕见的肉瘤样癌，且前列腺特异性抗原（PSA）水平正常。
Front Oncol. 2024 Sep 5;14:1456390. doi: 10.3389/fonc.2024.1456390. eCollection 2024.
2
The role of inflammatory processes and zinc levels in prostatic enlargement among Iraqi samples.伊拉克样本中炎症过程和锌水平在前列腺增大中的作用。
J Med Life. 2023 Sep;16(9):1388-1392. doi: 10.25122/jml-2023-0224.
3
Early Detection of Secondary Bladder Urothelial Carcinoma and Disseminated Bone Metastases with Normal Prostate-Specific Antigen Level after Pelvic Salvage Radiotherapy in Prostate Cancer.
前列腺癌盆腔挽救性放疗后前列腺特异性抗原水平正常时继发性膀胱尿路上皮癌和播散性骨转移的早期检测
Life (Basel). 2023 May 25;13(6):1249. doi: 10.3390/life13061249.
4
Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection.用于侵袭性前列腺癌检测的尿液前列腺特异性抗原和血清前列腺特异性抗原
Cancers (Basel). 2023 Feb 2;15(3):960. doi: 10.3390/cancers15030960.
5
The regulatory pathways leading to stem-like cells underlie prostate cancer progression.导致前列腺癌细胞具有干细胞样特性的调控途径是肿瘤发生发展的基础。
Asian J Androl. 2019 May-Jun;21(3):233-240. doi: 10.4103/aja.aja_72_18.
6
Galectin-3: a possible complementary marker to the PSA blood test.半乳糖凝集素-3：一种可能作为前列腺特异性抗原血液检测补充标志物的物质。
Oncotarget. 2013 Apr;4(4):542-9. doi: 10.18632/oncotarget.923.
7
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?一次采血能否替代经直肠超声估计的前列腺体积来预测前列腺癌风险？
BJU Int. 2013 Sep;112(5):602-9. doi: 10.1111/j.1464-410X.2012.11690.x. Epub 2013 Feb 28.
8
Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients.前列腺癌患者精浆中Dickkopf 相关蛋白 3 水平升高。
J Transl Med. 2011 Nov 10;9:193. doi: 10.1186/1479-5876-9-193.
9
Dutasteride: a review of its use in the management of prostate disorders.度他雄胺：其在前列腺疾病管理中的应用综述
Drugs. 2008;68(4):463-85. doi: 10.2165/00003495-200868040-00008.